BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home » Newsletters » BioWorld

BioWorld

March 13, 2017

View Archived Issues

Fighting peanut allergies before the attacks start

For children and adults with peanut allergies, the only therapeutic option comes from post-exposure treatment with epinephrine, such as Epipen (Mylan NV) or Auvi-q (Kaleo Inc.), to dampen the anaphylactic reaction. Even then, 100 to 150 people die from food allergies each year. Read More

AMPs take aim at AMRs as biopharma seeks new solutions to resistance

Antimicrobial resistance (AMR) is a topic that just won't go away, and for good reason. Despite the plethora of threats facing humankind, including thousands of diseases in need of therapies or cures, many scientists worry that the biggest risk of extinction comes from the deadly pathogens that exist in uneasy cohabitation on planet Earth. Tensions mounted in 2015 after the mcr-1 gene was detected on plasmids in China and Europe and were heightened last year with the first U.S. case of a patient with an infection resistant to a last-resort antibiotic. Read More

Money raised by biotech in 2017 vs. 2016

Read More

Money raised by biotech: Jan. 1 - March 9, 2017

Read More

Nasdaq Stock Index 2016

Read More

BioWorld Stock Index 2016

Read More

BioWorld stock report for public biotechnology companies

Read More

The week's biggest gainers and losers

Read More

Week in review

Read More

Word on the street

Read More

Public financing of biotechnology companies: Commenced trading in February 2017

Read More

Public financing of biotechnology companies: Filed and pending IPOs in February 2017

Read More

2016 top private financings of public companies

Read More

2016 top financings of private companies

Read More

Other financings of public biotechnology companies: February 2017

Read More

Venture capital & other investments in private biotech companies: February 2017

Read More

Milestone payments from corporate partners: February 2017

Read More

Week in Washington

Read More

Popular Stories

  • Today's news in brief

    BioWorld

    BioWorld briefs for March 24, 2026.

  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • Art concept for Parkinson's disease

    Emerging therapeutic strategies for Parkinson’s at ADPD 2026

    BioWorld
    Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 24, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing